Matthew Dellatorre
Stock Analyst at Goldman Sachs
(4.61)
# 1,032
Out of 4,988 analysts
24
Total ratings
100%
Success rate
55.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Dellatorre
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals | Reiterated: Buy | $21 | $18.71 | +12.24% | 10 | Aug 10, 2026 | |
| TEVA Teva Pharmaceutical Industries | Reiterated: Buy | $45 → $50 | $38.98 | +28.27% | 10 | Apr 30, 2026 | |
| VTRS Viatris | Reiterated: Hold | $10 → $12 | $16.95 | -29.20% | 4 | Oct 22, 2025 |
Amneal Pharmaceuticals
Aug 10, 2026
Reiterated: Buy
Price Target: $21
Current: $18.71
Upside: +12.24%
Teva Pharmaceutical Industries
Apr 30, 2026
Reiterated: Buy
Price Target: $45 → $50
Current: $38.98
Upside: +28.27%
Viatris
Oct 22, 2025
Reiterated: Hold
Price Target: $10 → $12
Current: $16.95
Upside: -29.20%